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Abstract
Background/Aim. Many studies support the hypothesis that
oxidative stress is involved in the pathogenic process of a vari-
ety of diseases including hypertension. In humans, hyperten-
sion is also considered a state of oxidative stress that can con-
tribute to the development of arteriosclerosis and other hy-
pertension-induced organ damage. The  aim of this study was
to evaluate an influence of acute physical exercise on antioxi-
dative enzymes activity and lipid status in patients with hyper-
tension. Methods. Fourty patients with hypertension and 20
age-matched controls were included in the study. To assess an
influence of acute exercise on lipids and antioxidative enzymes
activity the following parameters were determined at rest and
immediately after the acute cardiopulmonary exercise cycloer-
gometer test: triglycerides (TG), total cholesterol, low density
cholesterol (LDL), oxidised LDL cholesterol (OxLDL), su-
peroxide dismutase (SOD), glutathione peroxidase (GSH-Px)
and plasminogen activator inhibitor (PAI). Results. In basal
condition, hypertensive patients compared to the control
group had  increased, but not significantly, level of Ox LDL
(88.61±14.06  vs 79.00±29.26 mmol/L),  PAI (3.06±0.56 vs
2.6±0.35 U/mL)  and activity of GSH-Px (50.22±15.20 vs
44.63±13.73 U/g Hb). After acute exercise test, there was sig-
nificantly greater level of Ox LDL (79.0±29.26 vs 89.3±29.07
mmol/L; p < 0.05) only in the  control  group. GSH-Px activ-
ity was significantly decreased only in hypertensive patients
after acute exercise (50.22±15.2 vs 42.82±13.42 U/g Hb;
p <  0.05), but not in the controls. Conclusion. No signifi-
cantly elevated Ox LDL, GSH-Px and PAI-1 levels were
found in hypertensive patients during basal condition in com-
parison with healthy subjects. Decreased GSH-Px activity was
associated with those in acute exercise only in hypertensive
patients. It could be an important indicator of deficiency of
physiological antioxidative defense mechanism in hypertensive
patients during an acute exercise.
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Apstrakt
Uvod/Cilj. Mnoga ispitivanja podupiru hipotezu da je oksida-
tivni stres uključen u patogenezu različitih bolesti uključujući i
hipertenziju. S druge strane smatra se da je hipertenzija kod čo-
veka stanje oksidativnog stresa koje sudeluje u razvoju arterios-
kleroze i drugih poremećaja izazvanih hipertenzijom. Cilj ove
studije bio je da se proceni uticaj akutnog fizičkog napora na
aktivnost antioksidativnih enzima i lipidni status kod bolesnika
sa hipertenzijom. Metode. U ispitivanje bilo je uključeno 40
bolesnika sa hipertenzijom i 20 zdravih osoba iste starosti. Kod
njih su u stanju mirovanja, kao i neposredno posle aerobnog
treninga (ergometrijskog testa) određivani sledeći parametri: tri-
gliceridi (TG), ukupni holesterol, lipoproteini male gustine
(LDL), oksidisani LDL holesterol (Ox LDL), superoksid dis-
mutaza (SOD), glutation peroksidaza (GSH-Px), inhibitor akti-
vatora plazminogena (PAI). Rezultati. U bazalnim uslovima
bolesnici sa hipertenzijom u odnosu na kontrolnu grupu imali
su viši nivo Ox LDL (88,61±14,06 vs 79,00±29,26 mmol/L),
PAI (3,06±0,56 vs 2,6±0,35 U/mL) i  aktivnost GSH-Px
(50,22±15,20 vs 44,63±13,73 U/g Hb), koji nije dostigao nivo
statističke značajnosti (p > 0,05). Tokom ergometrijskog testa
uočen je statistički značajan porast koncentracije Ox LDL u
odnosu na bazalni nivo (79,0±29,26 vs 89,3±29,07 mmol/L,
p < 0,05) samo u kontrolnoj grupi. Aktivnost GSH-Px statistič-
ki je značajno opala samo kod bolesnika sa hipertenzijom na-
kon sprovedenog ergometrijskog testa (50,22±15,2 vs
42,82±13,42 U/g Hb; p < 0,05), ali ne i kod ispitanika  kon-
trolne grupe. Zaključak. Nisu nađeni značajno viši nivoi Ox
LDL,  PAI-1 i GSH-Px u bazalnim uslovima kod bolesnika sa
hipertenzijom u odnosu na ispitanike kontrolne grupe. Nakon
fizičke aktivnosti kod bolesnika sa hipertenzijom uočeno je sta-
tistički značajno sniženje aktivnosti GSH-Px. Ovo bi mogao
biti važan pokazatelj nedostatka fiziološkog mehanizma antiok-
sidativne odbrane kod bolesnika sa hipertenzijom izloženih
akutnom fizičkom naporu.
Ključne reči:
hipertenzija; vežbanje; oksidoreduktaze; trigliceridi;
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Introduction
Many studies support the hypothesis that oxidative
stress is involved in the pathogenic process of a variety of
diseases including hypertension 
1, 2. In humans, hypertension
is also considered a state of oxidative stress that can contrib-
ute to the development of arteriosclerosis and other hyper-
tension-induced organ damage 
3.
Lipid peroxidation and reduced antioxidant defense
mechanisms are important factors affecting oxidation of
lipoproteins and thereby the progression of arteriosclerotic
disease 
1, 3.
An enhanced oxidative stress has been observed in hy-
pertensive patients as indicated by increased free radicals
production, lipid peroxidation and diminished antioxidant
status 
3–5. Assessment of antioxidant activities and lipid per-
oxidation byproducts in hypertensive subjects indicates an
excessive amount of reactive oxygen species (ROS) and a
reduction of antioxidant mechanism activity in both blood
and several other cellular systems including not only vascu-
lar cells but also those found in circulating blood 
3, 6.
Experimental and clinical evidence has demonstrated
impairment of endothelium function caused by oxidative
products in patients 
3.
Antioxidant system includes non-enzymatic components
and enzymatic ones such as glutathione peroxidase (GSH-Px),
superoxide dismutase (SOD), and catalase (CAT) 
1, 2.
It is known that exercise induces oxidative stress. There
are many studies on exercise training and hypertension, but
very few on exercise-induced oxidative stress and antioxi-
dant activities in hypertensive patients 
5–7. It has been shown
that reduction of superoxide radicals by infusion of super-
oxide dismutase (SOD) significantly decreases blood pres-
sure in spontaneously hypertensive rats 
7.
Exercise, paradoxically, is a well recognized model of
oxidative stress and also an important therapeutic tool in hy-
pertensive patients. Reduction of activity of antioxidant sys-
tem could be a cause of increased oxidative state during ex-
ercise. Since physical activity protects against the develop-
ment of cardiovascular disease (CVD) and modifies risk
factors as plasminogen activator inhibitor (PAI), a regular
exercise program seems to be desirable. There is a biochemi-
cal paradox: considerable amounts of oxygen are necessary
to obtain a good performance and a satisfactory cardiopul-
monary status, while an excess of oxygen or a defective me-
tabolism of it could be harmful 
8, 9 .
In relation to antioxidant enzymes, an increase of SOD
and GSH-Px activities has been observed in skeletal muscle,
heart and liver during a single bout of acute exercise 
10 . It is
important that physical training induces enhancement of
muscular and liver antioxidant enzymes, mainly GSH-Px, fa-
cilitating the removal of reactive oxygen species and the re-
duction of oxidative stress levels 
8.
The aim of this study was to estimate lipid oxidation
and antioxidant parameters during basal conditions and after
submaximal exercise test in a group of untreated hyperten-
sive subjects, compared with gender- and age-paired healthy
controls.
Methods
The study population consisted of consecutive outpa-
tients from the Endocrinology and Cardiology Departments
of University Clinical Center “Dr Dragiša Mišović”, Bel-
grade. We evaluated 40 patients with hypertension (20 males
and 20 females), aged 51.19±8.37  years and 20 age- and
gender-matched controls (healthy, normotensive nonsmok-
ers). Exclusion criteria were secondary arterial hypertension,
diabetes, coronary artery disease, rhythm disturbances, cere-
brovascular disease, chronic obstructive lung disorder or se-
vere renal failure. Essential hypertension was defined ac-
cording to the criteria of the VI Joint National Committee
WHO grade I – II, non treated for hypertension.
For providing an objective assessment of exercise capacity
and impairment we applied cardiopulmonary exercise cycle er-
gometer test (Jaeger Oxycon Delta ER - 900). All study subjects
underwent a symptom-limited incremental test protocol with
25W increments each 3 minutes. Test was designed to be pro-
gressive and incremental in order to elicit the important pa-
rameters: VO2 max (mL/min) - maximal O2 uptake; FAI index
(%) - maximal O2 uptake compared to predictive value; VO2/Kg
(mL/Kg/min) - uptake related to body weight; VE (L/min) -
ventilation per minute; RER - respiratory exchange ratio an-
aerobic threshold; T - time to anaerobic threshold (min). Heart
rate and rhythm were continuously monitored using a 12 lead
electrocardiogram. Blood pressure was measured before each
load change. Gas analyses and flow probes were calibrated be-
fore each test. Gas exchange data were collected in a breath by
breath manner and averaged into 30-second time period. All pa-
rameters were calculated as highest 30-second time period re-
corded before volitional fatigue was reached. Test lasted from 3
to 12 min depending on physical condition. Blood pressure was
measured with a mercury sphygmomanometer, with a patient in
the sitting position after a 5-minute rest.
This investigation was approved by the Ethical Com-
mittee of University Clinical Centre “Dr Dragiša Mišović”,
Belgrade.
Lipid parameters triglyceride, total cholesterol, HDL
and LDL cholesterol, oxidized LDL cholesterol (mmol/L)
were measured from serum.
Triglycerides (TG) were measured by an enzymatic
colorimetric method (Elitech).
HDL-cholesterol was measured after precipitation of
LDL and VLDL by phosphotungstic acid (Serbolab).
LDL-cholesterol was calculated according to the
Friedwald formula.
Oxidised LDL-cholesterol was measured by the Elisa
method (Mercodia) from serum.
Plasminogen activator inhibitor-type 1 (PAI-1) (U/mL)
was measured by the spectrophotometer method using a
commercial kit (Behring).
Superoxide dismutase (SOD) (U/g Hb) was measured
by the enzymatic colorimetric method from erytrocyte after
centrifugation of 0.5 mL of whole blood for ten minutes at
3 000 rpm and then aspiration off the plasma. Erytrocytes
were washed 4 times with 3 mL of 0.9% Na Cl solution and
centrifuged for 10 minutes at 3 000 rpm after each wash. TheVolumen 66, Broj 9 VOJNOSANITETSKI PREGLED Strana 697
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washed centrifuged erytrocytes should then be made up to 2.0
mL with cold redistilled water, mixed and left to stand at +4
C° for 15 minutes. The lysat was diluted with Ransot sample
diluent, so that the % of inhibition fell between 30% and 60%.
The activity of SOD was measured at 500 nm with a
commercially available kit (Randox Laboratories, kit Ransod
superoxide dismutase) by testing the inhibition degree of a
tetrazolium salt oxidation reaction. The coefficient of vari-
ability between assays was 4.2%.
The activity of GSH-Px (U/g Hb) was evaluated by a
commercial kit (Ransel glutathione peroxidase, Randox
Laboratories) in erythrocytes at 340 nm by measuring the
decrease of NADPH absorbancy. The coefficient of variabil-
ity between assays was 4%.
All data were expressed as mean ± standard deviations (SD).
Statistical analysis was done by a Statistical Package
for the Social Sciences Program (SPSS). Comparisons of all
measurements were made with the paired Student's t-test and
Mann-Whitney U test. Simple and multiple linear regression
analysis determined all correlations.
Differences between groups were considered significant
at p < 0.05.
Results
All demographics and biochemical parameters are
shown in Tables 1 and 2.  Table 2 shows that during basal
condition, oxidised LDL cholesterol (Ox LDL), GSH-Px and
PAI-1 were increased, but not significantly, in the hyperten-
sive patients as compared to those of the controls.
There was no change in SOD activity between hyper-
tensive and healthy subjects, before and after the exercise
(Table 2). The patients with hypertension had significantly
decreased levels of GSH-Px after exercise (p < 0.05).  Ox
LDL cholesterol was significantly increased during acute ex-
ercise only in the healthy subjects (p < 0.05) (Table 2).
Peak oxygen uptake (VO2) was significantly greater in
the healthy group (p < 0.01). There were no significant dif-
ferences between hypertensive patients and healthy subjects
for exercise time and ventilation per minute (VE). There was
a negative correlation between VO2 peak and Ox LDL before
exercise (r = -0.65, p < 0.05) (Table 3).
  Systolic and diastolic blood pressure were significantly
higher during exercise in the hypertensive group (p < 0,01) (Ta-
ble 4). There was no correlation between blood pressure (BP)
and antioxidant enzymes (GSH-Px and SOD) activity.
Table 1
Clinical and biochemical parameters in the hypertensive patients and the control group
Parameters Control group (healthy subjects)
(n = 20)
Hypertensive group
(n = 40)
Female/male 10/10 20/20
Body mass index (kg/m
2) 25.01 ± 1.90 26.82 ± 3.14
Glycemia (mmol/L) 5.08 ± 0.68 – rest
4.92 ± 0.74  – exercise
5.41 ± 0.95 – rest
5.39 ± 0.87  –  exercise
Tryglycerides (mmol/L) 1.74 ± 0.9 – rest
1.98 ± 0.8  –  exercise
2.08 ± 1.35 – rest
2.22 ± 1.09  –  exercise
Total cholesterol (mmol/L) 5.57 ± 1.67 – rest
5.9 ± 1.88  –  exercise
6.62 ± 0.78 – rest
6.78 ± 0.69  –  exercise
LDL cholesterol (mmo/L) 3.61 ± 1.56 – rest
3.55 ± 1.55  –  exercise
4.42 ± 0.82 – rest
4.65 ± 0.64  –  exercise
PAI-1 (U/mL) 2.6 ± 0.35 – rest
2.22 ± 0.65 – exercise
3.06 ± 0.56 – rest
2.87 ± 0.93 – exercise
Table 2
Indicators of oxidative stress and antioxidative defense before and after the acute exercise
in the hypertensive and the control group
Hypertensive group (n = 40) Control group (n = 20) Indicators rest exercise rest exercise
Ox LDL (mmol/l) 88.61 ± 24.06 95.3 ± 22.51 79.0 ± 29.26 89.3 ± 29.07*
SOD (U/g Hb) 904.7 ± 99.66 928.08 ± 73.66 877.14 ± 153.18 895.0 ± 193.49
GSH-Px (U/g Hb) 50.22 ± 15.2 42.82 ± 13.42* 44.63 ± 13.73 43.97 ± 25.97*
* p < 0.05 vs the basal value (at the rest)
Table 3
Respiratory and cardiovascular post-exercise data
in the hypertensive and the control group
Variable Hypertensive group Control group
VO2 peak (mL/min) 20.55 ± 6.73 26.35 ± 10.53*
VE            (L/min) 53.72 ± 14.07 52.00 ± 9.89
Exercise time (min) 13.58 ± 4.78 11.05 ± 1.48
* p < 0.01  vs the hypertensive group; VO2 oxygen uptake; VE = ventilation per minute
Table 4
Blood pressure before and during the exercise in the hypertensive and the control group
Hypertensive group Control group Blood pressure – BP (mmHg) Rest During exercise Rest During exercise
Systolic BP 139.65 ± 22.96 206.8 ± 22.9* 122.37 ± 12.09 128.0 ± 30.64
Diastolic BP  90.3 ± 12.04 103.75 ± 11.89*   80.0 ± 9.36    73.6 ± 16.56
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Discussion
There are some contradictory results in the literature re-
garding oxidative stress parameters and lipids in hyperten-
sive patients during acute exercise. The oxidation of LDL
cholesterol is considered the key event in initiation of arte-
riosclerosis 
9, 10. In our study OxLDL was increased but not
significantly in hypertensive patients in basal condition,
compared to the control group. On the other hand, we found
increased Ox-LDL after the exercise test only in the healthy
subjects. Our results are consistent with those of other stud-
ies on oxidative stress 
10, 11. It has been proposed that oxida-
tive stress may be associated with the pathogenesis of hy-
pertension and its complications 
11, 12.
In this study we observed an increase in GSH-Px activ-
ity in the hypertensive patients compared with the controls
during basal condition. In relation to acute exercise, a de-
crease in GSH-Px was observed only in the hypertensive pa-
tients. This finding is in accordance with that of Redon et al
3. There was no significant change in SOD activity in basal
condition and after exercise, in both groups (hypertensive
patients and controls). A possible explanation for these
findings is that the rise in some enzyme activities in the pa-
tients with hypertension could be a compensatory mecha-
nism of the body to prevent tissue damage 
13, 14.
Our results suggest that there seems to be an imbalance
between erytrocyte oxidant and antioxidant systems in pa-
tients with hypertension. This disturbance of the oxidative
metabolism may affect endothelial cell functions and con-
tribute to the development and maintenance of cardiovascu-
lar complications during hypertension. Reduced levels of
GSH-Px after acute bouts of exercise are related to an exten-
sive number of metabolic and gene expression disturbances
15–17. Whether a lower GSH-Px activity is a cause or a conse-
quence of an increased oxidative status, needs further
evaluation 
3.
The absence of a relationship between the BP values
and antioxidant parameters in the group of hypertensive
subjects may indicate that factors other than BP values alone,
such as an enhanced activity of angiotensin II or hyperinsuli-
nemia, may be responsible for altered oxidative state in
blood, which is in accordance with the previous studies 
18, 19.
In this study we found elevated concentrations in
plasma of PAI-1 only in patients with hypertension, in basal
condition. An acute exercise decreased the level of PAI-1
only in the healthy subjects, but not significantly. It has been
shown that an increased PAI-1 may contribute to accelera-
tion of atherosclerosis in condition characterized by insulin
resistance 
20, 21.
The evidence of a high oxidative profile during exercise
in hypertension is not directly related to an increase risk of
CVD 
22. An increase of antioxidant enzyme activity (GSH-
Px), related to the intensity of exercise after different levels
of training has also been described 
23. Accordingly, after a
regular physical training program an improvement in the
counterbalance of the oxidative stress could be expected.
Conclusion
It can be concluded that acute exercise induces an effect
well counterbalanced only in the healthy subject, but not in
the hypertensive patients.
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